Research Article
The Steady-State Serum Concentration of Genistein Aglycone Is Affected by Formulation: A Bioequivalence Study of Bone Products
Table 2
The maximal plasma concentration (), time to maximal plasma concentration (), areas under curve (AUC) and half-life () after steady administration of the medical food indicated for osteopenia/osteoporosis, the Squadrito study formulation, and the OTC bone supplement.
| ||||||||||||||||||||||||||||||||